<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">AMI</journal-id><journal-title-group><journal-title>Advances in Molecular Imaging</journal-title></journal-title-group><issn pub-type="epub">2161-6728</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ami.2014.41002</article-id><article-id pub-id-type="publisher-id">AMI-42310</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Computer Science&amp;Communications</subject><subject> Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Features of Glucose Metabolism in Pleomorphic Hyalinizing Angiectatic Tumor (PHAT)
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>o-Jui</surname><given-names>Chang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Cher-Wei</surname><given-names>Liang</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ching-Huei</surname><given-names>Kung</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ching-Shui</surname><given-names>Huang</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Chung-Huei</surname><given-names>Hsu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Department of Surgery, Cathay General Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff2"><addr-line>Department of Pathology, Cathay General Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff3"><addr-line>Department of Radiology, Taipei Medical University Hospital, Taipei, Taiwan</addr-line></aff><aff id="aff1"><addr-line>Department of Nuclear Medicine, Taipei Medical University Hospital, Taipei, Taiwan</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>chhsu@tmu.edu.tw(CH)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>13</day><month>01</month><year>2014</year></pub-date><volume>04</volume><issue>01</issue><fpage>11</fpage><lpage>13</lpage><history><date date-type="received"><day>November</day>	<month>11,</month>	<year>2013</year></date><date date-type="rev-recd"><day>December</day>	<month>11,</month>	<year>2013</year>	</date><date date-type="accepted"><day>December</day>	<month>18,</month>	<year>2013</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
   Pleomorphic Hyalinizing Angiectatic Tumor (PHAT) is a rare mesenchymal neoplasma. It is a pathological term describing a heterogeneous group of neoplasms of undetermined tumorigenesis and undefined malignancy. Based only on the morphological findings of histopathology, the biological potential of the tumor is indeterminate. Determination of glucose metabolism using FDG-PET revealed mildly increased FDG uptake in the tumor. We propose that FDG accumulation in the ectatic vessel, increased uptake of the pleomorphic cells and/or associated inflammatory cells, and increased permeability of the stroma lead to the imaging feature. 
 
</p></abstract><kwd-group><kwd>PHAT; FDG-PET; Sarcoma</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Pleomorphic Hyalinizing Angiectatic Tumor (PHAT), first described by Smith et al. in 1996 [<xref ref-type="bibr" rid="scirp.42310-ref1">1</xref>], is a rare lowgrade mesenchymal neoplasm that most often arises in the suprafascial subcutaneous areas of the extremities, and less frequently in the musculature of the limbs. Fewer than 100 cases have been described in the literature. Clinical features are slow-growing, non-metastasizing, locally infiltrative border, and borderline malignancy with a high rate of local recurrence. PHAT describes a heterogeneous group of neoplasms of undetermined tumorigenesis, characterized by clusters of ectatic, fibrinlined, and thin-walled vessels that are surrounded by spindled or pleomorphic neoplastic cells with variable inflammatory components. The neoplastic cells frequently have intracytoplasmic hemosiderin granules, intranuclear inclusions, and low mitotic activity [2-5]. Based only on the morphological findings of histopathology, the biological potential of the tumor is indeterminate. The level of fluorodeoxyglucose (FDG) uptake during positron emission tomography (FDG-PET) has been used as an in vivo method for identifying tumor metabolism and biological activity, as well as a prognostic indicator for malignancy. However, FDG uptake in PHAT has not been adequately described in the literature.</p></sec><sec id="s2"><title>2. Case Report</title><p>62-yrs-old male suffered from sigmoid colon cancer 18 years ago (aged 44, in 1995). A left inguinal hernioplasty with mesh support was performed simultaneously during the surgical resection of the tumor. Afterward, he received 5-FU adjuvant chemotherapy without local radiotherapy. A FDG-PET follow-up examination was performed in 2004, during which a focal area in the left inguinal region adjacent to the urinary bladder displayed increased FDG activity (Figures 1(a1) and (b1)). The maximum standard uptake value (SUVm) of the lesion was 3.2. Magnetic resonance imaging (MRI) showed a tumor in the corresponding region (<xref ref-type="fig" rid="fig2">Figure 2</xref>(a1) through <xref ref-type="fig" rid="fig2">Figure 2</xref>(a4)). A fixed, firm mass was detected by manual palpation of the left inguinal area. No other symp-</p><p>toms or signs were observed. The mass was considered an inflammatory pseudotumor resulting from the hernioplasty mesh because the SUVm of FDG was not high enough to indicate malignancy. This diagnosis was further supported by similar FDG-PET findings in subsequent follow-up examinations in 2006 and 2007 (Figures 1(a2) and (b2)) and (Figures 1(a3) and (b3)), and the follow-up MRI results that showed the size and the feature of the mass had remained unchanged (data not shown). No further signs or symptoms were observed during the remainder of the 17-year follow-up period (1995-2012). Bilateral hernioplasty was received on March 2012 because the symptoms of inguinal hernia had become exaggerated. During the accompanying MRI examination, changes in the size and contour of the inguinal lesion were noted (<xref ref-type="fig" rid="fig2">Figure 2</xref>(b)). Fordyce angiokeratoma was also diagnosed based on a number of purple papules on the scrotum, which is often associated with thrombophlebitis of the scrotum, varicocele, and inguinal hernia [<xref ref-type="bibr" rid="scirp.42310-ref6">6</xref>]. During laparotomy, a non-granulomatous tumor was surgically resected from the left rectus abdominis muscle. Gross examination of the tumor showed that it was well-circumscribed, lobulated, solid, and firm (<xref ref-type="fig" rid="fig3">Figure 3</xref>(a)), and the histopathology indicated that it was PHAT (Figures 3(b) and (c)). Up to now, he has been robust during one and half years of follow-up.</p></sec><sec id="s3"><title>3. Discussion</title><p>FDG-PET is a novel modality for metabolic imaging in clinical oncology. It was first used to differentiate benign and malignant lung tumors. However, the specificity of FDG-PET for estimating malignancy remains uncertain. Infection, inflammation, and certain benign pathological variants can mimic the FDG-uptake properties observed in malignancy, contributing to the misinterpretation of FDG-PET images [<xref ref-type="bibr" rid="scirp.42310-ref7">7</xref>]. Quantitative SUVm analysis of tumors is often recommended to discriminate between benign and malignant masses. However, cutoff values for malignancy have not been well defined, and considerable overlap between the SUVm of benign and malignant tumors has been observed. We previously reported the FDG-PET characteristics of three types of benign lesions. These consisted of an angiolipoma in the lower abdominal wall [<xref ref-type="bibr" rid="scirp.42310-ref8">8</xref>], a neurofibroma arising from para-spinal soft tissue [<xref ref-type="bibr" rid="scirp.42310-ref9">9</xref>], and a granuloma formed as a post-opera-</p><p>tive foreign body in the abdominal cavity [<xref ref-type="bibr" rid="scirp.42310-ref10">10</xref>]. We posited that inflammation, fibrin thrombi, and an ectatic, congestive vascular space had led to an increased accumulation of FDG (SUVm = 3.2) within the angiolipoma. The proliferative spindle cells of the neurofibroma and the intense inflammation associated with the granuloma were considered to have contributed to the increased FDG uptake (SUVm = 4.6 and 10.8, respectively) in those cases. Only one previous case of PHAT had been found at our institution [<xref ref-type="bibr" rid="scirp.42310-ref3">3</xref>], and that tumor had displayed mild FDG uptake (SUVm = 1.4) during FDG-PET examination. In PHAT, we propose that FDG accumulation in the ectatic vessel, increased uptake of the pleomorphic cells and/or associated inflammatory cells, and increased permeability of the stroma lead to the imaging feature. Whether high SUVm represents sarcomatous transformation of soft tissue neoplasms requires further correlation analysis with histopathological features and clinical outcomes. Folpe and Weiss proposed that PHAT is a neoplasm, rather than a reactive lesion [<xref ref-type="bibr" rid="scirp.42310-ref4">4</xref>]. The occurrence of PHAT in the inguinal area is rare [<xref ref-type="bibr" rid="scirp.42310-ref11">11</xref>], and the tumorigenesis in my case was unclear. However, the reaction of the tissues to surgical manipulation and/or the surgical mesh warrants consideration. The diagnosis of PHAT using MRI alone is unreliable. The features are variable, and notice should be taken when encountering an enhancing subcutaneous tumor with ill-defined margins [<xref ref-type="bibr" rid="scirp.42310-ref12">12</xref>].</p></sec><sec id="s4"><title>REFERENCES</title></sec><sec id="s5"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.42310-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">M. E. Smith, C. Fisher and S. W. Weiss, “Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts. A Low-Grade Neoplasm Resembling Neurilemoma,” American Journal of Surgical Pathology, Vol. 20, No. 1, 1996, pp. 21-29. http://dx.doi.org/10.1097/00000478-199601000-00002</mixed-citation></ref><ref id="scirp.42310-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Q. Ke, Erbolat, H. Y. Zhang, H. Bu, S. Li, D. N. Shi, et al., “Clinocopathology Features of Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts,” Chinese Medical Journal, Vol. 20, No., 2007, pp. 876-881.</mixed-citation></ref><ref id="scirp.42310-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">H. C. Peng, M. T. Huang, D. J. Chen, T. K. Leung and J. S. Chu, “Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts,” Journal of the Formosan Medical Association, Vol. 109, No. 8, 2010, pp. 616-620. http://dx.doi.org/10.1016/S0929-6646(10)60100-3</mixed-citation></ref><ref id="scirp.42310-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">A. L. Folpe and S. W. Weiss, “Pleomorphic Hyalinizing Angiectatic Tumor: Analysis of 41 Cases Supporting Evolution from a Distinctive Precursor Lesion,” American Journal of Surgical Pathology, Vol. 28, No. 11, 2004, pp. 1417-1425. http://dx.doi.org/10.1097/01.pas.0000141406.02581.fb</mixed-citation></ref><ref id="scirp.42310-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">S. Wei, Z. Pan, G. P. Siegal, T. S. Winokur, A. J. Carroll and D. Jhala, “Complex Analysis of a Recurrent Pleomorphic Hyalinizing Angiectatic Tumor of Soft Parts,” Human Pathology, Vol. 43, No. 1, 2012, pp. 121-126. http://dx.doi.org/10.1016/j.humpath.2011.02.023</mixed-citation></ref><ref id="scirp.42310-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">M. Machan and V. Konkovic-Capin, “Fordyce’s Angiokeratomas,” The New England Journal of Medicine, Vol. 366, 2012, p. 1240. http://dx.doi.org/10.1056/NEJMicm1104749</mixed-citation></ref><ref id="scirp.42310-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">S. Basu, T. Chryssikos, S. Moghadam-Kia, H. Zhuang, D. A. Torigian and A. Alavi, “Positron Emission Tomography as a Diagnostic Tool in Infection: Present Role and Future Possibilities,” Seminars in Nuclear Medicine, Vol. 39, No. 1, 2009, pp. 36-51. http://dx.doi.org/10.1053/j.semnuclmed.2008.08.004</mixed-citation></ref><ref id="scirp.42310-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">C. H. Hsu, C. M. Yang and C. H. Cheng, “Angiolipoma Detected by F-18 FDG Positron Emission Tomography,” Clinical Nuclear Medicine, Vol. 28, No. 7, 2003, pp. 604-605. http://dx.doi.org/10.1097/00003072-200307000-00019</mixed-citation></ref><ref id="scirp.42310-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">C. H. Hsu, C. M. Lee, F. C. Wang and C. L. Fang, “Neurofibroma with Increased Uptake of F-18-Fuloro-2 Deoxy-D-Glucose Interpreted as a Metastatic Lesion,” Annals of Nuclear Medicine, Vol. 17, No. 7, 2003, pp. 609-611. http://dx.doi.org/10.1007/BF03006677</mixed-citation></ref><ref id="scirp.42310-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">C. H. Hsu, C. M. Lee and S. Y. Lin, “Inflammatory Pseudotumor Resulting From Foreign Body in Abdominal Cavity Detected by FDG PET,” Clinical Nuclear Medicine, Vol. 28, No. 10, 2003, pp. 842-844. http://dx.doi.org/10.1097/01.rlu.0000090933.66898.d4</mixed-citation></ref><ref id="scirp.42310-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">M. Y. Choong, P. Z. Ke, C. Y. Huang and T. S. Li, “Pleomorphic Hyalinizing Angiectatic Tumor in the Inguinal area: A Potential Diagnostic Pitfall,” The American Surgeon Journal, Vol. 78, No. 1, 2012, pp. E45-46.</mixed-citation></ref><ref id="scirp.42310-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">T. K. Subhawong, A. P. Subhawong, E. A. Montgomery and L. M. Fayad, “Pleomorphic Hyalinizing Angiectatic Tumor: Imaging Finding,” Skeletal Radiology, Vol. 41, No. 12, 2012, pp. 1621-1626. http://dx.doi.org/10.1007/s00256-012-1443-0</mixed-citation></ref></ref-list></back></article>